1 – 10 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Insights on Genetic and Environmental Factors in Parkinson's Disease from a Regional Swedish Case-Control Cohort
(
- Contribution to journal › Article
-
Mark
RIC3 variants are not associated with Parkinson's disease in large European, Latin American, or East Asian cohorts
(
- Contribution to journal › Article
-
Mark
Effect Modification between Genes and Environment and Parkinson's Disease Risk
(
- Contribution to journal › Scientific review
- 2021
-
Mark
The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease
(
- Contribution to journal › Article
- 2019
-
Mark
Low prevalence of known pathogenic mutations in dominant PD genes : A Swedish multicenter study
(
- Contribution to journal › Article
-
Mark
Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease
(
- Contribution to journal › Article
- 2018
-
Mark
Glutathione S-transferase alpha 4 prevents dopamine neurodegeneration in a rat alpha-synuclein model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Immunogenetics of Parkinson's disease
2018) p.27-44(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Animal Models of Parkinson’s Disease
2018) p.83-106(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Microglia in neurological diseases : A road map to brain-disease dependent-inflammatory response
(
- Contribution to journal › Scientific review